NOVO — Februar 2026
-
Du kan gå til chathistorik. Her kan du på fuld skærm læse tilbage til 2009.
-
-
Recepttal for Wegovy-pillen vidner om stærk vækst men fortæller ikke alt pointerer analytiker https://proinvestor.com/investornyt/1413708/recepttal-for-wegovy-pillen-vidner-om-staerk-vaekst-men-fortaeller-ikke-alt-pointerer-analytiker
-
Novo nærmer sig vigtige data: Danske Bank spår tæt løb https://proinvestor.com/investornyt/1413710/novo-naermer-sig-vigtige-data-danske-bank-spar-taet-lob
-
$NVO gets a price target cut from David Evans at Kepler Cheuvreux.
PT lowered to DKK 400 from DKK 430, with the Buy recommendation maintained.
-
Winkel foreslået til Novos bestyrelse https://borsen.dk/nyheder/virksomheder/novo-foreslar-genmab-topchef-til-bestyrelsen
-
Novo Nordisk vil have Genmabs topchef i bestyrelsen https://proinvestor.com/investornyt/1413719/novo-nordisk-vil-have-genmabs-topchef-i-bestyrelsen
-
Kontra
@KontraInvest
$NVO: The Oral revolution is realThe latest IQVIA data (week ending Feb 13, 2026) confirms what we've been waiting for: The Wegovy pill is indeed a massive market expander.
Total Wegovy TRx hit 319,621 (+11.9% week over week), driven largely by the pill's HUGE growth in its sixth week. -
Key Insights:
Pill power: Wegovy pill TRx reached 56,943, a +49% jump week-over-week. This accounted for nearly 18% of total Wegovy prescriptions.Market share shift: Wegovy’s share of weekly TRx rose to 36.6% (up from 33.2%), while Zepbound saw a -3.8% decrease to 552,809.
-
Expansion, not cannibalization: Injectable volume is still growing alongside the pill. The oral form factor is bringing in sidelined patients who were needle-avoidant, not just switching existing users.
Starter dose dominance: Novo gained 16k in starter dose TRx while Lilly lost 4k. This is the lead indicator for future long-term volume.
These are very strong numbers and indicators!.
-
-
Novo Nordisk Stock Investors Just Got Great News From Eli Lilly https://www.fool.com/investing/2026/02/20/novo-nordisk-stock-great-news-eli-lilly/
-
The ‘Last 20 Pounds’ Pill The new Wegovy is for people who never thought they would use a GLP-1. https://www.thecut.com/article/new-wegovy-pill-users-postpartum-menopause.html?utm_source=twitter&utm_medium=s1&utm_campaign=nym
-
Endnu engang interessant at se ind i, hvordan andre mennesker i en anden kulturkreds tænker og handler: Her 40 årige kvinder i USA, der ønkser at tabe sig, så de bliver "set" af andre (ikke specielt sexuelt) på arbejde, i fritiden mv. - Der er helt overordnet et andet pres på kvinder i USA i forhold til f.eks Europa, hvor der også er et "naturligheds" ideal og en generel mere woke indstilling... Artiklen emmer af lettelse og eufori: - Det bliver stort i USA.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind